Citius Pharmaceuticals Inc (CTXR)
0.3454
-0.01
(-3.76%)
USD |
NASDAQ |
Nov 04, 16:00
0.346
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Cash from Financing (Quarterly): 13.72M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 13.72M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | |
| September 30, 2023 | -0.0007M |
| June 30, 2023 | 13.80M |
| March 31, 2023 | 0.0313M |
| December 31, 2022 | |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 16.80M |
| March 31, 2021 | 103.67M |
| December 31, 2020 | 0.0005M |
| September 30, 2020 | 8.700M |
| June 30, 2020 | 8.171M |
| March 31, 2020 | 6.027M |
| December 31, 2019 | 0.0001M |
| September 30, 2019 | 6.290M |
| June 30, 2019 | 4.834M |
| March 31, 2019 | 0.0072M |
| December 31, 2018 | 0.016M |
| September 30, 2018 | 8.927M |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.764M |
| December 31, 2017 | 6.608M |
| September 30, 2017 | 6.437M |
| June 30, 2017 | 2.54M |
| March 31, 2017 | 0.8389M |
| December 31, 2016 | 1.067M |
| September 30, 2016 | 0.4352M |
| June 30, 2016 | 0.429M |
| March 31, 2016 | 4.096M |
| December 31, 2015 | 0.3024M |
| September 30, 2015 | 0.4304M |
| June 30, 2015 | 0.8191M |
| March 31, 2015 | 0.26M |
| December 31, 2014 | 0.00 |
| June 30, 2014 | 0.05M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.575M |
| September 30, 2013 | 0.0074M |
| June 30, 2013 | 0.0032M |
| March 31, 2013 | 0.0097M |
| December 31, 2012 | 0.0002M |
| September 30, 2012 | 0.0054M |
| June 30, 2012 | 0.0061M |
| March 31, 2012 | 0.0065M |
| December 31, 2011 | 0.0022M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0007M
Minimum
Sep 2023
103.67M
Maximum
Mar 2021
10.05M
Average
0.0005M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Agilent Technologies Inc | -246.00M |
| Seelos Therapeutics Inc | 0.742M |
| Cara Therapeutics Inc | -0.61M |
| Moleculin Biotech Inc | -0.025M |
| Citius Oncology Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.367M |
| Free Cash Flow | -29.09M |
| Free Cash Flow Per Share (Quarterly) | -0.0481 |
| Free Cash Flow Yield | -51.76% |